News

Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study

BRENTWOOD, Tenn., Aug. 27, 2024 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax") today announced the results of a Cardiovascular Health Outcomes Analysis...

Capital Rx Launches Never Move Again™, Enabling Self-Funded Plan Sponsors to Perpetually Access the Best Drug Prices Without Ever Having to Reimplement a Plan, Reissue Cards, or Expose Members to Unnecessary Disruption

Gartner Recognizes Infinx as Sample Vendor for Intelligent Prior Authorization in Hype Cycle for US Healthcare Payers 2024 for Third Consecutive Year

CUPERTINO, CA / ACCESSWIRE / August 27, 2024 / Infinx Healthcare, a leading provider of AI-driven patient access and revenue...

error: Content is protected !!